Literature DB >> 1335649

Clinical manifestations and diagnosis of hepatitis A virus infection.

R S Koff1.   

Abstract

Hepatitis A is an acute, necroinflammatory disease of the liver which results from infection by the hepatitis A virus (HAV). The mean incubation period is approximately 30 days. Although the disease is usually self-limited, the severity of illness is age-dependent. In children, hepatitis A is usually asymptomatic, while in adults, symptomatic infection is characteristic and jaundice is common. Fulminant hepatitis A is rare and is also age-dependent. The onset of hepatitis A is often abrupt and characteristic prodromal symptoms are followed, within a few days to a week, by dark urine and jaundice. Mild to moderate tenderness over an enlarged liver is usually detected. Serum alanine and aspartate aminotransferase levels usually both rise rapidly during the prodromal period, reach peak levels and then decrease by approximately 75% per week. Serum bilirubin concentrations reach peak levels later and decline less rapidly than serum aminotransferases. Nonetheless, the period of jaundice persists for < 2 weeks in approximately 85% of cases. Nearly all adult patients with clinically apparent disease experience complete clinical recovery with restoration of normal serum bilirubin and aminotransferase values by 6 months. Relapses and prolonged cholestasis are unusual manifestations of hepatitis A, and even in these circumstances, recovery is the rule and chronic hepatitis is not seen. The diagnosis of hepatitis A requires the detection of immunoglobulin M antibody to HAV in a patient who presents with, or has recently had, clinical features of hepatitis (icteric or anicteric disease) or in an individual with inapparent, asymptomatic infection in whom serum aminotransferase elevations may be detected.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335649     DOI: 10.1016/0264-410x(92)90533-p

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  35 in total

1.  Cost-benefit analysis of active vaccination campaigns against hepatitis A among daycare centre personnel in Israel.

Authors:  G Chodick; Y Lerman; T Peled; H Aloni; S Ashkenazi
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 2.  Immunodiagnosis of viral hepatitides A to E and non-A to -E.

Authors:  G Yang; G N Vyas
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

3.  A comparative study of hepatitis caused by scrub typhus and viral hepatitis A in South Korea.

Authors:  Jun Lee; Dong-Min Kim; Na Ra Yun; Yu Mi Byeon; Young Dae Kim; Chan Guk Park; Man Woo Kim; Mi Ah Han
Journal:  Am J Trop Med Hyg       Date:  2011-11       Impact factor: 2.345

4.  Interchangeability of a hepatitis A vaccine second dose: Avaxim 80 following a first dose of Vaqta 25 or Havrix 720 in children in Turkey.

Authors:  Ahmet Soysal; Ibrahim Gokçe; Tamer Pehlivan; Mustafa Bakir
Journal:  Eur J Pediatr       Date:  2007-02-22       Impact factor: 3.183

Review 5.  New developments in hepatitis A control.

Authors:  L Yuan
Journal:  Can Fam Physician       Date:  1995-07       Impact factor: 3.275

6.  Anti-hepatitis A virus immunoglobulin M antibodies in urine samples for rapid diagnosis of outbreaks.

Authors:  Licel de los Angeles Rodríguez Lay; Osmany Larralde Díaz; Raiza Martínez Casanueva; Aidonis Gutiérrez Moreno
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

7.  Current hepatitis A status in Canada.

Authors:  J Wu; S Zou; A Giulivi
Journal:  Can J Infect Dis       Date:  2001-11

8.  Risk of hepatitis A infection in sewage workers.

Authors:  R Brugha; J Heptonstall; P Farrington; S Andren; K Perry; J Parry
Journal:  Occup Environ Med       Date:  1998-08       Impact factor: 4.402

9.  Clinical Features and Transmission Pattern of Hepatitis A: An Experience from a Hepatitis A Outbreak Caused by Two Cocirculating Genotypes in Sri Lanka.

Authors:  Niroshana J Dahanayaka; Tomoko Kiyohara; Suneth B Agampodi; Pradeep K Samaraweera; Gayani K Kulasooriya; Jagath C Ranasinghe; Saveen N Semage; Sayaka Yoshizaki; Takaji Wakita; Koji Ishii
Journal:  Am J Trop Med Hyg       Date:  2016-07-05       Impact factor: 2.345

10.  Molecular epidemiology of hepatitis A virus in the South-East area of Gyeonggi-do in Korea.

Authors:  Han Ul Song; Seong Gyu Hwang; Chang-Il Kwon; Ji Eun Lee; Kwang Hyun Ko; Sung Pyo Hong; Phil Won Park; Kyu Sung Rim
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.